A New Blood Test for Prostate Cancer Detection
The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection
This project is developing a new blood test to help doctors more accurately find prostate cancer and reduce the need for painful biopsies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11128523 on NIH RePORTER |
What this research studies
Current prostate cancer screening methods often lead to many men undergoing unnecessary biopsies or missing important cancers. This project is working on a new approach using tiny particles called Extracellular Vesicles (EVs), which are released by cancer cells into body fluids like blood. We are developing a special technique to specifically capture EVs that come from prostate cancer cells, identified by a protein called PSMA. This aims to create a more accurate 'liquid biopsy' to better distinguish between aggressive and non-aggressive prostate cancer. The goal is to help doctors make more informed decisions about who truly needs a biopsy, reducing discomfort and anxiety for patients.
Who could benefit from this research
Good fit: Men who are undergoing prostate cancer screening or have elevated PSA levels and are considering a prostate biopsy might be ideal candidates for future applications of this research.
Not a fit: Patients who have already been diagnosed with prostate cancer or are not undergoing screening for the condition may not directly benefit from this specific detection method.
Why it matters
Potential benefit: If successful, this new test could significantly reduce the number of men who undergo unnecessary prostate biopsies and improve the accuracy of detecting serious prostate cancer.
How similar studies have performed: While the concept of liquid biopsies for cancer detection is promising, this specific method of enriching PSMA-expressing extracellular vesicles for prostate cancer is a novel approach being developed in collaboration with experts in the field.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Punnen, Sanoj — University of Miami School of Medicine
- Study coordinator: Punnen, Sanoj
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.